Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Mosseri Marlio Charles. Officer active across 1 company, notably Nuvectis Pharma, Inc.. Cumulatively, 23 disclosures have been recorded. Split: 23 buys · 0 sell. Total volume traded: €4.1m. Activity tracked since 15 June 2023. The latest transaction was disclosed on 12 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations 23 total
21,167 shares @ US$8.11 3.7% of flow Common Stock SEC:0001104659-25-047938:0
Ideal exit: 6 Feb 2026 (T+270) 100 shares @ US$8.99 0.0% of flow Common Stock SEC:0001104659-25-047089:0
Ideal exit: 2 Feb 2026 (T+270) 2,340 shares @ US$8.40 0.4% of flow Common Stock SEC:0001104659-25-046882:0
Ideal exit: 31 Jan 2026 (T+270) 240,000 shares @ US$5.00 28.0% of flow Common Stock SEC:0001104659-25-011588:0
Ideal exit: 4 Nov 2025 (T+270) 32,121 shares @ US$4.64 3.4% of flow Common Stock SEC:0001104659-24-129009:0
Ideal exit: 8 Sept 2025 (T+270) 17,000 shares @ US$4.70 1.8% of flow Common Stock SEC:0001104659-24-128688:0
Ideal exit: 9 Sept 2025 (T+270) 860 shares @ US$13.88 0.3% of flow Common Stock SEC:0001104659-23-086060:0
Ideal exit: 26 Apr 2024 (T+270) 2,584 shares @ US$13.91 0.8% of flow Common Stock SEC:0001104659-23-085603:0
Ideal exit: 23 Apr 2024 (T+270) 1,556 shares @ US$13.98 0.5% of flow Common Stock SEC:0001104659-23-085087:0
Ideal exit: 22 Apr 2024 (T+270) 10,000 shares @ US$13.97 3.1% of flow Common Stock SEC:0001104659-23-084523:0
Ideal exit: 21 Apr 2024 (T+270) 5,394 shares @ US$14.40 1.7% of flow Common Stock SEC:0001104659-23-083470:0
Ideal exit: 15 Apr 2024 (T+270) 8,000 shares @ US$14.84 2.6% of flow Common Stock SEC:0001104659-23-082536:0
Ideal exit: 14 Apr 2024 (T+270) 9,149 shares @ US$14.84 2.9% of flow Common Stock SEC:0001104659-23-082196:0
Ideal exit: 13 Apr 2024 (T+270) 3,285 shares @ US$15.09 1.1% of flow Common Stock SEC:0001104659-23-080572:0
Ideal exit: 7 Apr 2024 (T+270) 10,000 shares @ US$15.36 3.4% of flow Common Stock SEC:0001104659-23-080178:0
Ideal exit: 6 Apr 2024 (T+270) 8,948 shares @ US$15.19 3.0% of flow Common Stock SEC:0001104659-23-079339:0
Ideal exit: 2 Apr 2024 (T+270) 3,179 shares @ US$15.01 1.1% of flow Common Stock SEC:0001104659-23-078942:0
Ideal exit: 1 Apr 2024 (T+270) 1,176 shares @ US$15.52 0.4% of flow Common Stock SEC:0001104659-23-078475:0
Ideal exit: 31 Mar 2024 (T+270) 16,760 shares @ US$16.46 6.1% of flow Common Stock SEC:0001104659-23-075031:0
Ideal exit: 22 Mar 2024 (T+270) 73,175 shares @ US$17.43 28.2% of flow Common Stock SEC:0001104659-23-074561:0
Ideal exit: 19 Mar 2024 (T+270) 6,091 shares @ US$17.71 2.4% of flow Common Stock SEC:0001104659-23-074060:0
Ideal exit: 17 Mar 2024 (T+270) 12,700 shares @ US$17.75 5.0% of flow Common Stock SEC:0001104659-23-072614:0
Ideal exit: 12 Mar 2024 (T+270) 400 shares @ US$17.54 0.2% of flow Common Stock SEC:0001104659-23-071869:0
Ideal exit: 11 Mar 2024 (T+270)